Published in J Gastroenterol on April 13, 2016
Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease. Dig Dis Sci (2016) 0.77
Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J (1955) 19.22
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
Ulcerative colitis. N Engl J Med (2011) 6.14
Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (2010) 5.20
Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology (2011) 4.88
Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol (2007) 2.68
Effects of family history on inflammatory bowel disease characteristics in Japanese patients. J Gastroenterol (2012) 2.17
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol (2009) 2.12
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology (2001) 1.71
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut (2007) 1.62
Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev (2004) 1.61
Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol (1995) 1.52
HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci (1995) 1.45
Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol (2009) 1.39
Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol (2009) 1.36
Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis (2009) 1.22
The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation. Lipids Health Dis (2011) 1.00
Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study. Aliment Pharmacol Ther (2008) 0.92
Biological and histological parameters as predictors of relapse in ulcerative colitis: a prospective study. Saudi J Gastroenterol (2011) 0.89
Restorative proctectomy with ileal pouch-anal anastomosis in obese patients. Dis Colon Rectum (2010) 0.87
Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.86
Ethnicity differences in genetic susceptibility to ulcerative colitis: a comparison of Indian asians and white northern Europeans. Inflamm Bowel Dis (2013) 0.83
Fecal calprotectin levels predict the clinical course in patients with new onset of ulcerative colitis. Inflamm Bowel Dis (2013) 0.82
Predictors of permanent ileostomy after restorative proctocolectomy. Br J Surg (2010) 0.80
Improvement in the visibility of colorectal polyps by using blue laser imaging (with video). Gastrointest Endosc (2015) 0.98
First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis. J Gastroenterol (2015) 0.88
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial. J Crohns Colitis (2016) 0.85
Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan. Intest Res (2016) 0.81
Long-term course of Crohn's disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery. J Gastroenterol Hepatol (2015) 0.80
Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study. Intest Res (2016) 0.79
Lipid is absorbed in the stomach by epithelial neoplasms (adenomas and early cancers): a novel functional endoscopy technique. Endosc Int Open (2015) 0.79
Surveillance for Dysplasia in Patients with Ulcerative Colitis: Discrepancy between Guidelines and Practice. Dig Endosc (2017) 0.78
Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease. Kidney Int (2015) 0.78
Genetic characteristics of inflammatory bowel disease in a Japanese population. J Gastroenterol (2015) 0.78
Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease. J Crohns Colitis (2016) 0.77
CDX2 expression induced by leukocytapheresis might be associated with mucosal healing in ulcerative colitis. J Gastroenterol Hepatol (2016) 0.77
Tacrolimus for the Treatment of Ulcerative Colitis. Intest Res (2015) 0.76
Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents. Sci Rep (2016) 0.76
Magnetic resonance enterography for the evaluation of the deep small intestine in Crohn's disease. Intest Res (2016) 0.76
Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186. Mucosal Immunol (2016) 0.76
A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility. Eur J Hum Genet (2016) 0.75
Evaluation of Interferon Resistance in Newly Established Genotype 1b Hepatitis C Virus Cell Culture System. J Clin Transl Hepatol (2016) 0.75
Increased childhood BMI is associated with young adult serum uric acid levels: a linkage study from Japan. Pediatr Res (2016) 0.75
Pre-illness isoflavone consumption and disease risk of ulcerative colitis: a multicenter case-control study in Japan. PLoS One (2014) 0.75
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Sci Rep (2016) 0.75
The nature of the white opaque substance within colorectal neoplastic epithelium as visualized by magnifying endoscopy with narrow-band imaging. Endosc Int Open (2016) 0.75
Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis. J Crohns Colitis (2016) 0.75
Need for appropriate programs for prevention of hepatitis B infection: Lessons from the latest nationwide survey in Japan. J Gastroenterol Hepatol (2016) 0.75
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2). J Gastroenterol (2019) 0.75
Increased childhood body mass index is associated with young adult serum uric acid levels: a linkage study from Japan. Pediatr Res (2016) 0.75
Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol (2017) 0.75
Involvement of herbal medicine as a cause of mesenteric phlebosclerosis: results from a large-scale nationwide survey. J Gastroenterol (2016) 0.75
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. J Med Virol (2016) 0.75
Risk factors for decreased bone mineral density in inflammatory bowel disease: A cross-sectional study. Clin Nutr (2015) 0.75
Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: a network meta-analysis. J Gastroenterol Hepatol (2016) 0.75
ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin. Hepatol Res (2017) 0.75
Efficacy of Indigo naturalis in a Multicenter Randomized Controlled Trial of Patients with Ulcerative Colitis. Gastroenterology (2017) 0.75
Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Hepatol Res (2016) 0.75
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Park 1: risk assessment. J Gastroenterol Hepatol (2017) 0.75
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management. J Gastroenterol Hepatol (2017) 0.75